Evaluate performance of the Abbott chemiluminescent microparticle immunoassay assay for detection of syphilis infection in Chinese blood donors
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.23033
Abstract: To prevent Treponema Pallidum (TP) transmission from blood transfusion, enzyme‐linked immunosorbent assay (EIA) for anti‐TP has been widely used in routine blood donation screening in China for many years. The aim of this study was… read more here.
Keywords: assay detection; chinese blood; blood donors; performance abbott ... See more keywords
Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Medical Microbiology"
DOI: 10.1099/jmm.0.001372
Abstract: Introduction The ID NOW is FDA approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of symptom onset for COVID-19 if tested within 1 h of specimen collection. Gap statement Clinical data… read more here.
Keywords: abbott among; study; performance abbott; performance ... See more keywords
Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12051172
Abstract: Background: We evaluated the performance of the Abbott N-terminal pro-brain natriuretic peptide (NT-proBNP) assay against the Roche NT-proBNP immunoassay across two sites. Methods: Precision, linearity, and sensitivity studies were performed. A combined method of comparison… read more here.
Keywords: abbott; abbott architect; probnp assay; performance abbott ... See more keywords